UNSPSC 51384901: Firocoxib

This classification denotes a cyclooxygenase inhibitor with the molecular formula C17H20O5S, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y6V2W4S4WT, chemically known as 3-(cyclopropylmethoxy)-5,5-dimethyl-4-(4-(methylsulfonyl)phenyl)furan-2(5h)-one but generally known as firocoxib, which bears US NIH Compound Identifier 208910. The term FIROCOXIB is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 18, No. 1, 2004, List 51).

As of Q4 2014, FIROCOXIB remains the US FDA Preferred Term for this commodity. Firocoxib bears US NLM identifiers UMLS ID C1453102 and NCI Concept Code C65686. SMILES: CC1(C(=C(C(=O)O1)OCC2CC2)C3=CC=C(C=C3)S(=O)(=O)C)C.

UNSPSC 51384901 Firocoxib, a Commodity code, does not align with the recent state and local procurement activity tagged under it. The three most recent opportunities—Seminole County's procurement of naloxone and drug deactivation systems, Texas HHS's RFI on direct-to-manufacturer prescription programs, and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products—address broad pharmaceutical supply, opioid-reversal agents, and pharmacy benefit management infrastructure rather than firocoxib, a veterinary anti-inflammatory drug with no demonstrated state or local government demand. The code shows no relevant recent solicitation activity grounded in actual firocoxib purchasing.

The mismatch suggests either a tagging error in the underlying procurement database or dormant activity under this commodity code. Firms pursuing pharmaceutical supply contracts with state and local governments should monitor the broader pharmaceutical and OTC product families (evidenced by MMCAP's two-year generic multi-source RFP in Minnesota and Oregon, Seminole County's naloxone buys through competitive sealed bidding, and Texas HHS's exploratory RFI) rather than relying on firocoxib-specific opportunities, which do not appear in current state and local procurement pipelines.